Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.87
-0.02 (-0.34%)
Mar 30, 2026, 9:47 AM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 105.3 billion as of March 27, 2026. Its market cap has increased by 74.42% in one year.
Market Cap
105.30B
Enterprise Value
110.80B
Revenue
35.43B
Ranking
n/a
PE Ratio
40.78
Stock Price
5.87
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 105.30B, an increase of 31,811.65%. That is a compound annual growth rate of 25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 105.30B | -4.69% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 240.33B |
| Innovent Biologics | 137.77B |
| WuXi Biologics | 130.50B |
| Akeso | 113.95B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.66B |
| RemeGen | 64.84B |
| 3SBio | 54.25B |
| Biocytogen Pharmaceuticals (Beijing) | 36.79B |